Boceprevir for untreated chronic HCV genotype 1 infection

Medicine & Life Sciences

• N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide 100%
• Chronic Hepatitis C 67%
• Hepacivirus 59%
• Ribavirin 57%
• Genotype 45%
• Sustained Virologic Response 34%
• Infections 30%
• African Continental Ancestry Group 18%
• peginterferon alfa-2b 10%
• Placebos 8%
• Protease Inhibitors 6%
• Double-Blind Method 6%
• Standard of Care 6%
• Anemia 5%
• RNA 4%
• Therapeutics 4%
• Control Groups 3%